Megadalton Solutions — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Megadalton Solutions is a specialized analytical services company leveraging proprietary Charge Detection Mass Spectrometry (CD-MS) technology to solve critical characterization challenges for large macromolecules and nanoparticles. Founded in 2020 based on pioneering academic research, it offers a high-throughput, high-resolution platform essential for developers of gene therapies, vaccines, and novel nanoparticle drug delivery systems. The company operates as a fee-for-service CRO, providing data and expert analysis to biopharma clients, positioning itself at the intersection of advanced instrumentation, proteomics, and AI-driven data interpretation in the growing biophysical characterization market.

ProteomicsAI / Machine Learning

Technology Platform

Charge Detection Mass Spectrometry (CD-MS) enhanced with AI/ML for high-resolution mass and charge measurement of single, large macromolecules and nanoparticles (e.g., AAVs, DNA, VLPs).

Opportunities

The rapid growth of gene therapies, vaccines, and nanoparticle-based drugs creates massive demand for advanced characterization tools.

Megadalton's CD-MS technology offers a superior solution for critical quality attributes like AAV capsid ratios, positioning it to become a standard service for biopharma CMC and regulatory filings.

Expansion into new modalities and potential development of proprietary software or instrumentation present additional growth avenues.

Risk Factors

Primary risks include slow adoption of CD-MS versus established analytical methods by a conservative biopharma industry, requiring significant validation efforts.

Competition from other CROs using different techniques and the potential for instrument manufacturers to commercialize CD-MS systems could threaten the service-based model.

As a small, young company, execution risk in scaling operations and commercial presence is also significant.

Competitive Landscape

Megadalton competes in the biophysical characterization services market against CROs offering techniques like analytical ultracentrifugation (AUC), cryo-electron microscopy (cryo-EM), and light scattering. Its key differentiation is the single-particle, high-mass-range capability of CD-MS. Direct competitors are few but include other academic labs and potentially small firms commercializing similar CD-MS technology. Its value proposition is combining unique hardware with expert data analysis.

More companies in Diagnostics & Precision Medicine →More companies in United States →